GLP-1 Medications for Weight Loss Now Available!

The state of Florida currently has 2 active clinical trials seeking participants for Weight Loss research studies. These trials are conducted in various cities, including Miami, Tampa, Jacksonville and Orlando.
A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications
Recruiting
The objective of this study is to assess self-reported gastrointestinal (GI) responses to three snack bars containing fiber/fiber blends vs. a control snack bar for 7 days each in adults using GLP-1 agonists.
Gender:
ALL
Ages:
Between 25 years and 64 years
Trial Updated:
06/06/2025
Locations: Excellence Medical and Research, Miami Gardens, Florida +1 locations
Conditions: Gastrointestinal Symptoms, Weight Loss, GLP-1
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Recruiting
This is a phase 2, 13-week randomized, double-blind, placebo-controlled, parallel arm dose-finding study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of VK2735 Oral Formulation in adults who are obese (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid condition. VK2735 or matched placebo will be administered once daily.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/19/2025
Locations: Viking Clinical Site #101, Clearwater, Florida +3 locations
Conditions: Weight Loss